146 related articles for article (PubMed ID: 21904383)
1. Overexpression of GATA2 predicts an adverse prognosis for patients with acute myeloid leukemia and it is associated with distinct molecular abnormalities.
Vicente C; Vazquez I; Conchillo A; García-Sánchez MA; Marcotegui N; Fuster O; González M; Calasanz MJ; Lahortiga I; Odero MD
Leukemia; 2012 Mar; 26(3):550-4. PubMed ID: 21904383
[No Abstract] [Full Text] [Related]
2. GATA2 mutations are frequent in intermediate-risk karyotype AML with biallelic CEBPA mutations and are associated with favorable prognosis.
Fasan A; Eder C; Haferlach C; Grossmann V; Kohlmann A; Dicker F; Kern W; Haferlach T; Schnittger S
Leukemia; 2013 Feb; 27(2):482-5. PubMed ID: 22814295
[No Abstract] [Full Text] [Related]
3. A rare but specific subset of adult AML patients can be defined by the cytogenetically cryptic NUP98-NSD1 fusion gene.
Fasan A; Haferlach C; Alpermann T; Kern W; Haferlach T; Schnittger S
Leukemia; 2013 Jan; 27(1):245-8. PubMed ID: 22945772
[No Abstract] [Full Text] [Related]
4. Classification of CEBPA mutated acute myeloid leukemia by GATA2 mutations.
Marceau-Renaut A; Guihard S; Castaigne S; Dombret H; Preudhomme C; Cheok M
Am J Hematol; 2015 May; 90(5):E93-4. PubMed ID: 25611491
[No Abstract] [Full Text] [Related]
5. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.
Lugthart S; Gröschel S; Beverloo HB; Kayser S; Valk PJ; van Zelderen-Bhola SL; Jan Ossenkoppele G; Vellenga E; van den Berg-de Ruiter E; Schanz U; Verhoef G; Vandenberghe P; Ferrant A; Köhne CH; Pfreundschuh M; Horst HA; Koller E; von Lilienfeld-Toal M; Bentz M; Ganser A; Schlegelberger B; Jotterand M; Krauter J; Pabst T; Theobald M; Schlenk RF; Delwel R; Döhner K; Löwenberg B; Döhner H
J Clin Oncol; 2010 Aug; 28(24):3890-8. PubMed ID: 20660833
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of Gata-1, Gata-2, EKLF, and c-MPL expression in acute myeloid leukemia.
Ayala RM; Martínez-López J; Albízua E; Diez A; Gilsanz F
Am J Hematol; 2009 Feb; 84(2):79-86. PubMed ID: 19097174
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetics in acute leukemia.
Mrózek K; Heerema NA; Bloomfield CD
Blood Rev; 2004 Jun; 18(2):115-36. PubMed ID: 15010150
[TBL] [Abstract][Full Text] [Related]
8. [Age-specific characteristics of acute myeloid leukemia karyotype].
Gritsaev SV; Martynkevich IS; Martynenko LS; Ivanova MP; Aksenova VIu; Moskalenko MV; Zapreeva IM; Abdulkadyrov KM
Ter Arkh; 2011; 83(1):51-5. PubMed ID: 21446203
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of telomere erosion and its association with genome instability in myelodysplastic syndromes (MDS) and acute myelogenous leukemia arising from MDS: a marker of disease prognosis?
Sieglová Z; Zilovcová S; Cermák J; Ríhová H; Brezinová D; Dvoráková R; Marková M; Maaloufová J; Sajdová J; Brezinová J; Zemanová Z; Michalová K
Leuk Res; 2004 Oct; 28(10):1013-21. PubMed ID: 15289012
[TBL] [Abstract][Full Text] [Related]
10. Karyotype complexity and prognosis in acute myeloid leukemia.
Stölzel F; Mohr B; Kramer M; Oelschlägel U; Bochtler T; Berdel WE; Kaufmann M; Baldus CD; Schäfer-Eckart K; Stuhlmann R; Einsele H; Krause SW; Serve H; Hänel M; Herbst R; Neubauer A; Sohlbach K; Mayer J; Middeke JM; Platzbecker U; Schaich M; Krämer A; Röllig C; Schetelig J; Bornhäuser M; Ehninger G
Blood Cancer J; 2016 Jan; 6(1):e386. PubMed ID: 26771812
[TBL] [Abstract][Full Text] [Related]
11. High incidence of RAS signalling pathway mutations in MLL-rearranged acute myeloid leukemia.
Grossmann V; Schnittger S; Poetzinger F; Kohlmann A; Stiel A; Eder C; Fasan A; Kern W; Haferlach T; Haferlach C
Leukemia; 2013 Sep; 27(9):1933-6. PubMed ID: 23535558
[No Abstract] [Full Text] [Related]
12. Fifty-one patients with acute myeloid leukemia and translocation t(8;21)(q22;q22): an additional deletion in 9q is an adverse prognostic factor.
Schoch C; Haase D; Haferlach T; Gudat H; Büchner T; Freund M; Link H; Lengfelder E; Wandt H; Sauerland MC; Löffler H; Fonatsch C
Leukemia; 1996 Aug; 10(8):1288-95. PubMed ID: 8709633
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-inducible factor-1α protein expression is associated with poor survival in normal karyotype adult acute myeloid leukemia.
Deeb G; Vaughan MM; McInnis I; Ford LA; Sait SN; Starostik P; Wetzler M; Mashtare T; Wang ES
Leuk Res; 2011 May; 35(5):579-84. PubMed ID: 21176961
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic findings in adult secondary acute myeloid leukemia (AML): frequency of favorable and adverse chromosomal aberrations do not differ from adult de novo AML.
Preiss BS; Bergmann OJ; Friis LS; Sørensen AG; Frederiksen M; Gadeberg OV; Mourits-Andersen T; Oestergaard B; Kerndrup GB;
Cancer Genet Cytogenet; 2010 Oct; 202(2):108-22. PubMed ID: 20875873
[TBL] [Abstract][Full Text] [Related]
15. [Clinical and cytogenetics studies on acute myeloid leukemia with abnormality of chromosome 11].
Lu Y; Xu W; Chen Z; Lou J; Jin J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):583-5. PubMed ID: 18841578
[TBL] [Abstract][Full Text] [Related]
16. JAK2-V617F activating mutation in acute myeloid leukemia: prognostic impact and association with other molecular markers.
Vicente C; Vázquez I; Marcotegui N; Conchillo A; Carranza C; Rivell G; Bandrés E; Cristobal I; Lahortiga I; Calasanz MJ; Odero MD
Leukemia; 2007 Nov; 21(11):2386-90. PubMed ID: 17581610
[No Abstract] [Full Text] [Related]
17. Multiplex reverse transcription polymerase chain reaction screening in acute myeloid leukemia detects cytogenetically unrevealed abnormalities of prognostic significance.
Hutchings Hoffmann M; Wirenfeldt Klausen T; Hasle H; Schmiegelow K; Brondum-Nielsen K; Johnsen HE
Haematologica; 2005 Jul; 90(7):984-6. PubMed ID: 15996940
[TBL] [Abstract][Full Text] [Related]
18. Biological and clinical significance of cytogenetic study on 100 acute lymphoblastic leukemia and 219 acute non-lymphoblastic leukemia.
Ye J; Cao Q; Su X; Huang Q; Ma Z; Wang Z; Huang W; Chen Z; Chen S
Chin Med J (Engl); 1997 Feb; 110(2):90-5. PubMed ID: 9594276
[TBL] [Abstract][Full Text] [Related]
19. EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia.
Balgobind BV; Lugthart S; Hollink IH; Arentsen-Peters ST; van Wering ER; de Graaf SS; Reinhardt D; Creutzig U; Kaspers GJ; de Bont ES; Stary J; Trka J; Zimmermann M; Beverloo HB; Pieters R; Delwel R; Zwaan CM; van den Heuvel-Eibrink MM
Leukemia; 2010 May; 24(5):942-9. PubMed ID: 20357826
[TBL] [Abstract][Full Text] [Related]
20. 11q23 abnormalities in patients with acute myelogenous leukemia and myelodysplastic syndrome as detected by molecular and cytogenetic analyses.
Ibrahim S; Estey EH; Pierce S; Glassman A; Keating M; O'Brien S; Kantarjian HM; Albitar M
Am J Clin Pathol; 2000 Nov; 114(5):793-7. PubMed ID: 11068555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
